| Product Code: ETC7645164 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Artificial Intelligence (AI)-based Clinical Trials Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Artificial Intelligence (AI)-based Clinical Trials Market - Industry Life Cycle |
3.4 Israel Artificial Intelligence (AI)-based Clinical Trials Market - Porter's Five Forces |
3.5 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume Share, By Clinical Trial Phase, 2021 & 2031F |
3.6 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Israel Artificial Intelligence (AI)-based Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of AI technology in healthcare sector |
4.2.2 Growing demand for more efficient and cost-effective clinical trial processes |
4.2.3 Government initiatives and investments in AI research and healthcare |
4.3 Market Restraints |
4.3.1 Data privacy and security concerns in handling patient information |
4.3.2 Lack of skilled professionals in AI and healthcare sectors |
4.3.3 Regulatory challenges and compliance issues in implementing AI in clinical trials |
5 Israel Artificial Intelligence (AI)-based Clinical Trials Market Trends |
6 Israel Artificial Intelligence (AI)-based Clinical Trials Market, By Types |
6.1 Israel Artificial Intelligence (AI)-based Clinical Trials Market, By Clinical Trial Phase |
6.1.1 Overview and Analysis |
6.1.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Clinical Trial Phase, 2021- 2031F |
6.1.3 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Phase-I, 2021- 2031F |
6.1.4 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Phase-II, 2021- 2031F |
6.1.5 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Phase-III, 2021- 2031F |
6.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Neurological Diseases or Conditions, 2021- 2031F |
6.2.5 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.6 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Artificial Intelligence (AI)-based Clinical Trials Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Academia, 2021- 2031F |
6.3.4 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Artificial Intelligence (AI)-based Clinical Trials Market Import-Export Trade Statistics |
7.1 Israel Artificial Intelligence (AI)-based Clinical Trials Market Export to Major Countries |
7.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Imports from Major Countries |
8 Israel Artificial Intelligence (AI)-based Clinical Trials Market Key Performance Indicators |
8.1 Average time reduction in conducting clinical trials using AI |
8.2 Percentage increase in successful clinical trial outcomes with AI assistance |
8.3 Cost savings achieved in conducting AI-based clinical trials compared to traditional methods |
9 Israel Artificial Intelligence (AI)-based Clinical Trials Market - Opportunity Assessment |
9.1 Israel Artificial Intelligence (AI)-based Clinical Trials Market Opportunity Assessment, By Clinical Trial Phase, 2021 & 2031F |
9.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Artificial Intelligence (AI)-based Clinical Trials Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Israel Artificial Intelligence (AI)-based Clinical Trials Market - Competitive Landscape |
10.1 Israel Artificial Intelligence (AI)-based Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Israel Artificial Intelligence (AI)-based Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here